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Abstract
Introduction: Sustaining optimal adherence is the major challenge facing adolescents living with HIV (ALHIV), particularly in
low-resource settings, where “second-line” is often the last accessible treatment option. We explored the knowledge and skills
adolescents need in order to maintain improved adherence behaviours, and the specific ways clinicians and caregivers may
support young people to do so more independently.
Methods: We conducted individual, in-depth interviews with 20 ALHIV aged 10 to 18 years in Uganda in 2017 to 2018. All
participants had recently commenced second-line treatment as part of a clinical trial. We used thematic qualitative analysis to
examine adherence experiences and challenges while on first-line therapy, as well as specific supports necessary to optimise
treatment-taking longer-term.
Results: Adherence difficulties are exacerbated by relatively rapid shifts from caregiver-led approaches during childhood, to
an expectation of autonomous treatment-taking with onset of adolescence. For many participants this shift compounded their
ongoing struggles managing physical side effects and poor treatment literacy. Switching to second-line typically prompted
reversion back to supervised adherence, with positive impacts on self-reported adherence in the immediate term. However,
this measure is unlikely to be sustainable for caregivers due to significant caregiver burden (as on first line), and provided little
opportunity for clinicians to guide and develop young people’s capacity to successfully adopt responsibility for their own treat-
ment-taking.
Conclusions: As ALHIV in sub-Saharan Africa are attributed increasing responsibility for treatment adherence and HIV man-
agement, they must be equipped with the core knowledge and skills required for successful, self-directed care. Young people
need to be relationally supported to develop necessary “adherence competencies” within the supportive framework of a gradual
“transition” period. Clinic conversations during this period should be adolescent-focussed and collaborative, and treatment-tak-
ing strategies situated within the context of their lived environments and support networks, to facilitate sustained adherence.
The disclosure of adherence difficulties must be encouraged so that issues can be identified and addressed prior to treatment
failure.
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1 | INTRODUCTION
With vast improvements in survival resulting from effective
prevention of mother-to-child transmission (PMTCT) and
antiretroviral treatment (ART) for HIV in high-burden,
resource-stretched countries, adolescence has emerged as a
critical priority area for HIV care [1-3]. Limited improvements
in survival have been observed among this age-group relative
to their paediatric and adult counterparts [3,4], and morbidity
rates among adolescents in sub-Saharan Africa are not declin-
ing at the same pace as other age groups [3]. As for other
chronic conditions, provision of HIV care during adolescence
is characterised by unique management challenges as major
cognitive, psychosocial, physical and sexual developmental
changes take place [5-8]. This is illustrated by relatively poorer
HIV-care outcomes with high rates of attrition from clinical
care services [9-11] and compromised ART adherence
[10,12,13]. Accompanied by exploration of risk-associated
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sexual behaviours [14,15], this has far-reaching consequences
for individuals and public health outcomes alike [16,17].
Importantly, adolescence involves the shift of responsibility
for HIV care, from caregiver to adolescent [18]. To support
the development of mechanisms which enable independent
self-management of treatment compliance and health literacy
among adolescents, there is a need to characterise the pro-
cess of successful transition among adolescents, including
development of evidence-based approaches to guide clinicians
[10,19]. In high-burden, resource-stretched settings, the tran-
sition to adult care may not be demarcated by a discrete
movement between paediatric and adult facilities as occurs in
developed settings [20-23]. Thus, contextually appropriate
approaches to formalising this process are needed to facilitate
intentional adolescent capacity-development and treatment
continuity [9,24].
In this paper, we conceptualise “transition” as being the shift
young people make away from caregiver-driven (or “medi-
ated”) to increasingly autonomous, self-directed treatment-tak-
ing and HIV care; accompanying the broader,
contemporaneous developmental transition toward indepen-
dence. Our applied approach is grounded in the social-ecologi-
cal theory for transition preparedness [25,26]; incorporating
both individual elements of transition preparedness and con-
sideration of the influential role of the surrounding physical
and social environments and support systems [25,27]. We
investigated the challenges encountered by ALHIV during the
adolescent transition period, particularly those related to
treatment-taking, and identified core competencies required
to manage their health independently. And secondly, the speci-
fic ways in which clinicians and caregivers may equip ALHIV
with the knowledge and skills required for successful transi-
tion to “adult” HIV care.
2 | METHODS
We present the results of a qualitative study conducted
among 20 ALHIV (aged 10 to 18 years) attending a leading
HIV clinic in Kampala, Uganda. The clinic is well-resourced,
and offers separate paediatric and adult care. Transfer to adult
care typically occurs once a young person is in their early
twenties. This study was conducted over a 12-month time per-
iod: 2017 to 2018.
The study is a qualitative sub-study of the ongoing “ODYS-
SEY” trial (Once-daily DTG based ART in Young people versus
Standard thErapY) (NCT NCT02259127) [28]. The clinical trial
is an open-label, randomised, non-inferiority, basket trial evalu-
ating the efficacy and safety of DTG plus 2 nucleos(t)ides
(NRTIs) versus standard of care in HIV-positive adolescents
age <18 years starting first-line ART (ODYSSEY A) or switch-
ing to second-line (ODYSSEY B).
We recruited ALHIV who had experienced treatment failure
(ODYSSEY B), as identified by high viral load or morbidity.
These participants were presumed to be encountering adher-
ence challenges and had recently commenced second-line
treatment through the clinical trial. All clinical trial participants
who were eligible to take part in the qualitative study were
invited to do so, with the final five participants recruited pur-
posively to ensure a representative balance of age and gender
across the sample.
Data were collected using in-depth, semi-structured inter-
views, which were conducted by trained local researchers in a
private room within the paediatric clinic (caregivers were not
present). The interview guide was developed based on knowl-
edge from both the existing literature and the authors’ previ-
ous research, but primarily focused on generating detailed
accounts of individual experiences of treatment-taking within
its broader context. It was then revised and adapted in light
of emerging analytical areas of interest; including experiences
of growing up with HIV; ART-adherence; expectations of
adulthood and “adult” models of care; management of relation-
ships and onward disclosure. We present findings from the
first wave of interviews, in which participants reflected on
their treatment experiences on first-line therapy, prior to
switching.
All participants were aware of their HIV status prior to
recruitment. Appropriate national and institutional ethics
approvals were obtained, specifically, from the London School
of Hygiene and Tropical Medicine and the Joint Clinical
Research Centre, Uganda. Participant consent or assent were
obtained, and caregiver consent obtained for assenting partici-
pants aged younger than 18 years.
Audio-recorded interview data were transcribed verbatim
and then translated into English for analysis. Participant identi-
fying details were removed and pseudonyms applied. Tran-
script coding was done individually (manually) by the first and
last author. These initial codes were discussed and reconciled
into a Codebook. The Codebook was reviewed by the second
and third author, who were familiar with the data. A thematic
qualitative analysis was conducted, with emerging themes dis-
cussed between the authors to ensure the integrity of induc-
tive data interpretation (including understanding of nuances
specific to the local context). Deviant case analyses were con-
ducted to attain representative depth of analysis.
3 | RESULTS
Table 1 presents participant characteristics. The experiences
of participants reflected a range of diverse situations which
shaped their capacity to adhere to their HIV treatment. How-
ever, all participants had recently been moved onto second-
line ART, and all reported experiencing some challenges main-
taining optimal adherence.
3.1 | Individual-level (adolescent) considerations
3.1.1 | Evolving models of care
Our findings suggest adolescents are attributed more respon-
sibility for their treatment-taking with increasing age, with
dwindling involvement from their caregivers. Although partici-
pants anticipated becoming “fully responsible” for treatment-
taking “when [they] grow older” (George, male, age 10), we
argue this expectation often faltered in reality as they were
not adequately equipped with necessary accompanying knowl-
edge and strategies to successfully navigate and sustain the
complex demands of transition to self-care.
For several of our participants, the time period during which
they had assumed responsibility for their own treatment-tak-
ing predated them being disclosed to regarding their diagnosis
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and understanding the necessity of consistent treatment-tak-
ing [29,30]. Dennis, male, age 14, shared how this knowledge
deficit proved problematic for him:
“There were some problems, because there came a situation
when I didn’t know why I was taking this medicine, they
took long to tell me. . . I was not taking them because I
didn’t know what they were for so I asked myself why I had
to since I was young. . . I used to ask my mother many
times but she would just say that you must take them. . .
So when I stopped, on coming here the viral load went high
to about 2000, and we went to the counsellor and they
asked if I knew, and it was my mum to tell me. . . Before I
knew that I had HIV it was difficult because I just didn’t
understand why I had to yet others were not taking.”
3.1.2 | Knowledge deficits as a barrier to self-
management
Aligned with study inclusion criteria, all participants were
aware of their HIV-positive status. At the time of data col-
lection, however, HIV and related treatment literacy
remained variable and frequently limited. Participants
described garnering HIV-related information from non-spe-
cialist sources such as radio, television and overheard con-
versations between laypeople, and tended to absorb overly
simplistic, blunt and often distressing messages. Zack male,
age 15, recalls his reaction upon learning of his diagnosis in
this way:
“I got so scared. . . I knew that I was going to die. Why did
you think that you were going to die? They used to say
that HIV kills. Where did you hear this? Over the radio
and even amongst people.”
Relevant information is typically provided in clinic visits.
However, this appeared not to have been understood and
integrated into the young people’s knowledge. Thus, ambigu-
ous explanations given during childhood often persisted una-
mended [31] rather than increasing in sophistication with
maturity. Sophia, female, age 17, shared simply, “I was born
with HIV.” Some appeared unaware of their sizeable knowl-
edge gaps and did not know to enquire. When prompted,
however, many participants had specific questions related to
their illness which had not yet been voiced. Representative of
this issue, Denna, male, age 11, disclosed:
“Do you perhaps have any questions about your illness?
Yes, I have always wanted to know where HIV came from.
Have you ever asked your mother about this? Sometimes
she is too busy so I get scared to ask. What about at the
clinic? I fear the health care workers also. What do you
think will happen if you asked them? I don’t know but I
fear and sometimes I forget.”
Generally, understanding of specific administration require-
ments for treatment taking, such as appropriate timing, were
hazy. When asked the time he was meant to take his medica-
tion, Mark, male, age 12, responded, “any time that I want.”
Jasmine, female, aged 17, shared a different concern:
“Sometimes I would find myself late and I would give up
because I know that day is wasted. . . They told us that we
can only take the medication at most five minutes passed
the scheduled time.”
Others were aware that they needed to take treatment
every day, but struggled due to side-effects such as “headache
and nausea” (Zack, male, age 15), presuming these to be
unavoidable.
3.1.3 | Individual adherence strategies
At the time of being interviewed, all knew why they were
taking treatment, and the majority had grasped that adher-
ence was important. Sam, male, age 12, shared, “I want to
take my medication for my survival.” Similarly frightened by
the prospect of switching, Denna, male, age 11, resolved he
would “make an extra effort to take medication at all the
times [he was] supposed to take them.” However, renewed
commitment in the absence of additional support may be
less likely to succeed. A handful of participants had devised
individual strategies to support adherence. Teddy, female,
age 14, and Ethan, male, age 18, set alarms to prompt them
to take their treatment; Lazarus, male, age 18, took his at
the time of a particular television programme, and Mariam,
female, age 14, upon Muslim call to prayer. Jasmine, female,
age 17, initiated changing the time of administration to facili-
tate adherence:
“I would wake up late but I had to go to school and yet I
had not yet showered, so before I know it is getting to 7am
yet I have not yet taken my medication, so I decided to
change it.”
The development and use of these individual adherence
strategies indicates a willingness and evolving capacity to self-
care, however, these self-driven, apparently autonomous
approaches were exceptional; and the need for additional sup-
port is evidenced by their need to transition to second-line
therapy despite their individual efforts.
Table 1. Participant characteristics (n = 20)
Sex 12 male, 8 female
Median age (age range) 14.5 years (10 to 18 years)
Mode of HIV infection All participants had vertically acquired HIV
Antiretroviral therapy All participants were receiving
second-line ART therapy
Living situation/caregiver/s 13 were living with parent/s and 7 were
living with wider family
Education and employment 17 were attending school, 2 were
technical apprentices, 1 was employed
Clinical care centre All were receiving care from the same
paediatric HIV clinic
ART, antiretroviral therapy.
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3.2 | Interpersonal-level considerations (caregivers,
schools, workplaces)
3.2.1 | Caregiver-mediated treatment-taking
During childhood and early adolescence, capacity for self-care
exists within the framework of caregiver-dependence and sup-
port. Dan, male, age 17, shared; “they (grandparents) are the
ones who give me the money for transport to come to the
clinic, they also ensure that I have juice or milk to take with
my medication.” In later adolescence, some participants contin-
ued to benefit from caregiver support in contingency manage-
ment. Sheena, female, age 17, explained; “if I don’t feel well, I
let her (mother) know and she finds a solution.” Extended fam-
ily and siblings assisted with providing support for several par-
ticipants. In other accounts, however, caregivers were unsure
how to respond to concerns and crisis situations arising in the
home environment. Their capacity to respond appeared to be
determined by the extent to which they had been equipped
by healthcare workers with accessible resources and strate-
gies.
3.2.2 | Transfer, rather than transition, of
responsibility
Caregivers frequently struggled to juggle work and caring
commitments. Denna, male, age 11, shared his impression that
his mother was “too busy” to respond to questions about his
illness. Ethan, male, age 18, similarly explained his grand-
mother “is usually busy, so she may not know that I take my
medicine.” Given these limitations, transfer of responsibility for
treatment-taking may have necessarily occurred in an
unplanned, abrupt manner, rather than being implemented
gradually; leaving young people with unreliable treatment sup-
porters, or for some, “no people to remind or to help them”
(Sophia, female, age 17).
Being moved to second-line treatment prompted more
intensive adherence support, as Bob, male, age 15, recalls:
“because I was missing, they (caregivers) started to give me
my medication.” While reverting to caregiver-mediated treat-
ment taking may be initially helpful, this approach fails to
address underlying causes of non-adherence, and previous dif-
ficulties encountered by caregivers are likely to resurface;
making this unlikely to be a sustainable model of support.
3.2.3 | Caregiver-mediated competency development
A handful of participants shared strategies implemented by
their caregivers which developed their ability to self-manage
treatment-taking, evolving to a model of “supporting” rather
than “delivering” treatment. For example, Zack, male, aged 15,
reported; “I take my medication at the same time with mother,
so if one of us has forgotten we remind each other.” Dan,
male, aged 17, shared; “I keep my medicine in their (grandpar-
ents) bedroom on a table, so in the evenings I go with my milk
to their bedroom then I show them [that I] take the medicine.”
In both scenarios, the adolescent is encouraged to initiate tak-
ing treatment on time, but within a protective net of indirect
caregiver supervision. Other caregivers provided psychological
support for their children with notable benefit. Jasmine,
female, age 17, shared:
“I told him that I was fed up of taking the medication every
day, but he (father) told me that I have to take my medica-
tion, and I insisted and told him that I was fed up, then he
encouraged me.”
3.2.4 | Role of schools and workplaces
The benefit of collaboration with schools (and for older ado-
lescents, workplaces) also proved to be an essential aspect of
navigating impediments to treatment. For example, by approv-
ing absences necessary to attend HIV clinic appointments,
providing education (“they taught us about HIV in class;”
Sheena, female, age 17), combatting stigma when teachers
“treat us (HIV-positive children) just like the other children”
(Teddy, female, age 14), and discreetly storing and distributing
ART medication.
We found that maintaining the confidentiality of HIV status
was a universal priority, in light of significant concerns about
bullying and stigma, and yet many participants lacked strate-
gies to manage their treatment-taking discreetly in their
school, workplace and (for some) HIV-discordant home envi-
ronments. This issue created critical difficulties within board-
ing school contexts (in the absence of necessary support) as
Saidat, female, age 16, recalls:
“When I was in boarding school, I would be afraid to
remove my medication to take it in the presence of the
other students. . . because they will make fun of me or feel
disgusted by me, like they do with the other children.”
Lazarus, male, age 18, also avoided taking medication to
work because “the pills were too big, as soon as someone else
saw them they would instantly know. . . that I am sick.” Not
always verbalised, these issues persisted unacknowledged; and
in Saidat’s particular case, resulted in a period of compromised
adherence totalling “three years.”
3.3 | Organization-level considerations (providers,
clinicians)
3.3.1 | Adolescent-centred clinical interactions
The role of clinicians is central to the facilitation of transitions
towards inter-dependent self-management of treatment
adherence, however, we observed occasions where the struc-
ture of clinical interactions posed a significant barrier to their
potential effectiveness. We found that caregivers rather than
adolescents were often positioned at the centre of consulta-
tions, and that this had not necessarily evolved as they aged
(particularly for those who had attended the clinic since child-
hood). Mariam, female, age 14, described a recent appoint-
ment where she was not addressed directly by the clinician:
“Sometimes (the counsellor) speaks to me, but many times
she speaks to Mummy. Today what did you speak about
with the counsellor? She was writing in the file and
Mummy was answering her.”
Inadvertent exclusion of adolescents from clinical interac-
tions appeared to limit the development of their health
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literacy and ability to self-care, and emerged as being particu-
larly problematic when caregiver support was withdrawn.
Despite these challenges, enthusiasm to engage with clinicians
and in health education persisted. Teddy, female, age 14,
shared her (yet unmet) desire to learn more about HIV; “I like
coming here because I am keen to know about my health. Do
they tell you about your health when you come here? No they do
not tell me, but I would like to know.”
3.3.2 | Clinician-mediated competency development
It is revealing that participants were very responsive to
instances when clinicians had initiated discussion and provided
counselling. Jasmine, female, age 17, demonstrated how fos-
tering disclosure of adherence difficulties can lead to their
timely resolution, such as through joint problem solving;
“I told a health care worker that I take my medication in
the morning at 7am and when I come back from school at
6pm. . . but I told her that time is sometimes challenging
for me. The counsellor told me that I could choose a time
that was more convenient for me, and from that time I
started to choose the time when to take my medication
myself.”
In an environment where disclosure of HIV-positive status
remains complex and challenging in the community setting,
clinicians may be the only contacts other than the primary
caregiver or immediate family to be aware of an adolescent’s
HIV-positive status. Sheena, female, age 17, shared:
“I want to tell people what it is like for me taking the medi-
cine, I would like them to encourage me. Mainly things to
do with my treatment. . . I would like to speak to a friend.”
Clinicians have a potentially vital role to play as key sup-
porters of psychological as well as physical wellbeing; central
to holistic care and adolescent resilience. Teddy, female, age
14, shared the benefit she received by partaking in the clinical
trial: “the study helps encourage us to take our medication
well, and not feel sad and isolate ourselves.”
4 | DISCUSSION
In accordance with the wider chronic disease literature
describing best practice management during adolescence, our
findings indicate that a deliberate “transitional” period in HIV
care is required to facilitate successful transfer of HIV-man-
agement responsibility, from caregiver to adolescent [7,22-
23,32]. We suggest adopting a social-ecological approach to
the evolving model of care provision during this life-stage
[25], incorporating both individual elements of transition pre-
paredness, and harnessing the influential role of surrounding
physical and social environments and available support sys-
tems [25,27].
Individuals must be equipped with core competencies
required to engage with, and manage, the transition to auton-
omous treatment-taking and HIV care; for example, HIV liter-
acy, self-efficacy and skill-acquisition, beliefs, goals and
expectations, and psychosocial wellbeing [25,27]. The nature
and implications of their diagnosis, rationale and window of
opportunity to take treatment daily, and strategies to manage
missed doses and medication side-effects are essential to
adherence counselling. For this purpose, established “transition
checklists” may provide a valuable tool to broadly establish
the extent of individual transition preparedness and guide
ongoing care (where adapted, contextually suitable checklists
are available [33,34]). We suggest that HIV-counselling con-
tent increase in sophistication pre-emptively with evolving
maturity [35-37]. Ultimately, the optimal timing and rate of
adolescent transition should be tailored to the neurocognitive
developmental status of the individual, based on longitudinal
assessment and contemporaneous understanding of individual
capacity [25,38], rather than chronological age [39].
As young people mature, the relational influence of care-
givers (who typically determine the success of HIV care during
childhood) remains integral. However, the onset of adoles-
cence should herald the onset of a deliberate, developmentally
appropriate transition period which increasingly supports ado-
lescents to partner with their treating clinicians directly
[23,40]. Schools and workplaces may facilitate the transition
process by providing supportive environments; in particular,
by offering logistical assistance such as discreet treatment
storage and medical leave.
This approach emphasizes that effective care during the
transitional adolescent period entails a joint approach, which
actively involves clinician, caregiver and adolescent collabora-
tively in the therapeutic process [7,25,38]. Aligned with the
core foundation of social-ecological theory as pioneered by
Bronfenbrenner [41], the adolescent should be positioned at
the centre of the transition framework, and more specifically,
at the centre of clinical interactions. Such encounters should
foster an environment of uninhibited discussion, collaboration
and support [11,29,40,42]. We found that treatment regimens
were far more likely to be successful when they were devel-
oped in consultation with individual young people themselves
[6,21,23,43]. This may be achieved by eliciting and seriously
considering the priorities of ALHIV, such as preserving
secrecy of their HIV-positive status, engaging in education and
employment opportunities, establishing peer and intimate rela-
tionships, and maintaining realistic hope for the future [42,44-
47]. Treatment plans should be adapted to contextual factors
[6,8,23], such as by tailoring scheduled times for treatment-
taking to prevent conflict with school and work commitments.
In this way, regimen tolerability may be optimised, adherence
incentivized and barriers to adherence pre-emptively
addressed [39,48,49]. Similarly, when adherence is compro-
mised, rather than conceptualising a young person as having
“failed” in this regard (which may limit disclosure of future
adherence challenges [29,48]), they should be re-framed as
being the expert on their own individual circumstances
[48,50]. Thereby, encouraging the adolescent to engage with
caregivers and clinicians alike to identify their specific support
needs [13,37,39,48]. Provision of training for healthcare pro-
fessionals in the delivery of adolescent-centred care is likely
to convey benefit to HIV-care outcomes by optimising the effi-
cacy of therapeutic encounters [9,21,23,40]. Clinical interven-
tions should be paired with strategic engagement of
caregivers and relevant stakeholders (including teachers and
employers) to foster supportive environments; integral to ado-
lescent success during the transition period.
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4.1 | Strengths and limitations
Previous qualitative research conducted among children and
adolescents in similar settings has demonstrated their ten-
dency to ration the candour with which they speak about
adherence challenges, due to a desire to protect themselves
and their relationships with others; given the moralized nature
of discussions surrounding adherence [29,31,42]. A significant
strength of this study is the recruitment of participants who
had recently transitioned to second-line therapy. This provided
us with a unique opportunity to discuss adherence challenges
as being in the past, after they had been acknowledged;
thereby facilitating greater transparency in participants’
accounts.
A potential limitation of this study is that the clinic in which
it was conducted is a relatively well-resourced speciality HIV
centre, as such, our findings risk over-estimating the resources
available in smaller, more remote settings. Conscious of this,
we have focussed on transition as primarily taking place in
community settings (homes and schools) with clinician guid-
ance provided only during scheduled clinic appointments; an
approach which should be replicable.
5 | CONCLUSIONS
As ALHIV are attributed greater responsibility for their treat-
ment-taking and management, they must be equipped with
the essential knowledge and capabilities required. Our findings
suggest improved HIV outcomes in high-burden, resource-
stretched settings may be achieved through the implementa-
tion of an intentional “transition period” in HIV care, incremen-
tally supporting adolescents toward sustainable, autonomous
management. We suggest adopting a social-ecological
approach to transition care, whereby ALHIV are relationally
supported in clinic, home, school and workplace environments
to develop necessary “adherence competencies;” specifically,
through ongoing dialogue about HIV treatment literacy; rou-
tine management; identification of contingency strategies
should social or physical environmental factors impede treat-
ment taking; and disclosure of adherence difficulties as stan-
dard practice (allowing barriers to be addressed early). The
proposed approach acknowledges the evolving relationship
between adolescent, caregiver and clinician, and fosters effica-
cious collaboration in relation to HIV care throughout the
dynamic transition process.
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